Indiana University Urogynecology
Indianapolis, Indiana, 46032, United States
NCT Number: NCT04274491
The purpose of this study is to identify factors that influence a person's expectations regarding recovery from pelvic organ prolapse surgery. This is important because a person's expectations regarding recovery from surgery help to predict how a person will actually recover. Our hypothesis is that women with multiple roles will have expectations of a longer surgical recovery time after surgery for pelvic organ prolapse after controlling for known predictors of recovery expectancies. Participants will complete a preoperative online survey. Additional online surveys will be send on postoperative days 14 and 42 to measure postdischarge surgical recovery.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Indianapolis, Indiana, 46032, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Participant will complete preoperative survey at 1 day (once surgery is scheduled).
Expectation that recovery from surgery will be greater than 6 weeks from 0 to 100 percent where 100% indicates complete recovery within 6 weeks
Time frame: Questionnaire will be completed on post op day #14
Postdischarge Surgical Recovery Scale 13 which is validated tool for measuring postoperative recovery
Time frame: Questionnaire will be completed on post op day #42
Postdischarge Surgical Recovery Scale 13 which is validated tool for measuring postoperative recovery
Indiana University
Other
Predictors of Recovery Expectancy After Surgery for Pelvic Organ Prolapse
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05342090
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Calgary, Alberta, Canada
View Trial DetailsNCT03048682
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Weston, Florida, United States
View Trial DetailsNCT04198714
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Cleveland, Ohio, United States
View Trial DetailsNCT03040011
Neurologic Manifestations, Pain
Pittsburgh, Pennsylvania, United States
View Trial Details